Unknown

Dataset Information

0

Ion mobility spectrometry combined with multivariate statistical analysis: revealing the effects of a drug candidate for Alzheimer's disease on A?1-40 peptide early assembly.


ABSTRACT: Inhibition of the initial stages of amyloid-? peptide self-assembly is a key approach in drug development for Alzheimer's disease, in which soluble and highly neurotoxic low molecular weight oligomers are produced and aggregate in the brain over time. Here we report a high-throughput method based on ion mobility mass spectrometry and multivariate statistical analysis to rapidly select statistically significant early-stage species of amyloid-?1-40 whose formation is inhibited by a candidate theranostic agent. Using this method, we have confirmed the inhibition of a Zn-porphyrin-peptide conjugate in the early self-assembly of A?40 peptide. The MS/MS fragmentation patterns of the species detected in the samples containing the Zn-porphyrin-peptide conjugate suggested a porphyrin-catalyzed oxidation at Met-35(O) of A?40. We introduce ion mobility MS combined with multivariate statistics as a systematic approach to perform data analytics in drug discovery/amyloid research that aims at the evaluation of the inhibitory effect on the A? early assembly in vitro models at very low concentration levels of A? peptides.

SUBMITTER: Lazzaro S 

PROVIDER: S-EPMC6718366 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Ion mobility spectrometry combined with multivariate statistical analysis: revealing the effects of a drug candidate for Alzheimer's disease on Aβ1-40 peptide early assembly.

Lazzaro Serena S   Ogrinc Nina N   Lamont Lieke L   Vecchio Graziella G   Pappalardo Giuseppe G   Heeren Ron M A RMA  

Analytical and bioanalytical chemistry 20190812 24


Inhibition of the initial stages of amyloid-β peptide self-assembly is a key approach in drug development for Alzheimer's disease, in which soluble and highly neurotoxic low molecular weight oligomers are produced and aggregate in the brain over time. Here we report a high-throughput method based on ion mobility mass spectrometry and multivariate statistical analysis to rapidly select statistically significant early-stage species of amyloid-β1-40 whose formation is inhibited by a candidate thera  ...[more]

Similar Datasets

| S-EPMC4188271 | biostudies-other
| S-EPMC4078893 | biostudies-literature
| S-EPMC8327357 | biostudies-literature
| S-EPMC6271531 | biostudies-literature
| S-EPMC6747079 | biostudies-literature
| S-EPMC8176450 | biostudies-literature
| S-EPMC8363168 | biostudies-literature
| S-EPMC6812596 | biostudies-literature
| S-EPMC3664942 | biostudies-literature
| S-EPMC2930185 | biostudies-literature